Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

New cytokine-targeted therapies show promise for treating alopecia areata.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Obesity worsens skin health and losing weight can improve skin conditions.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Upadacitinib may effectively treat alopecia areata without side effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

People with lichen planus are more likely to have abnormal blood fats than healthy people.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Placental cell medium boosts blood vessel growth in lab tests.

The MPV/PC ratio can help assess disease activity in alopecia areata.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

RDW can be a useful marker for inflammation in alopecia areata patients.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Ayurvedic treatment improved hair growth in a person with hair loss.